Enrolling by invitationNCT01186913
Natural History Study of SCID Disorders
Studying Severe combined immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Christopher C. Dvorak, MDUCSF Children's Hospital
- Enrollment
- 690 enrolled
- Eligibility
- All sexes
- Timeline
- 2010 – 2028
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- University of California, Los Angeles, Los Angeles, California, United States
- Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, California, United States
- University of California San Francisco Children's Hospital, San Francisco, California, United States
- Children's Hospital Denver, Denver, Colorado, United States
- Alfred I. duPont Hospital for Children/Nemours, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Children's Hospital/Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States
- NIH Clinical Center Genetic Immunotherapy Section, Bethesda, Maryland, United States
- Children's Hospital Boston, Boston, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Primary Immune Deficiency Treatment Consortium (PIDTC) · Office of Rare Diseases (ORD) · National Center for Advancing Translational Sciences (NCATS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01186913 on ClinicalTrials.govOther trials for Severe combined immunodeficiency
Additional recruiting or active studies for the same condition.